Erythromycin Ethylsuccinate
NDC 62559-631, Erythromycin Ethylsuccinate, granule, for suspension, from ANI Pharmaceuticals, Inc..
- Product NDC
- 62559-631
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- GRANULE, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA062055
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62559-631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE400 mg/5mL
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62559-631-01 | 62559063101 | 100 mL in 1 BOTTLE (62559-631-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3d80f96e-3bbe-4fa5-89a8-694c61dd5e8fNADAC price for package 62559063101
GET /v1/drugs/nadac/62559063101
Use it
Look up 62559-631 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62559-631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62559-631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.